All In MedTech

Device Trial Radar · NCT05250908

INTIBIA Pivotal Study

A Prospective, Randomized Clinical Trial Evaluating INTIBIA, an Investigational Implantable Tibial Nerve Stimulator (INTIBIA Pivotal Study IU024)

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingTitle says "pivotal". Randomized with 208 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

208

Actual

Start

Mar 7, 2022

Primary completion

May 12, 2025

Study completion Jun 2029

Sponsor

Lead sponsor
Coloplast A/SNot on our public-company list
Sponsor type
Industry
First posted
Feb 22, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, randomized, double-blind, multicenter study to evaluate the safety and efficacy of an implantable tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

Conditions

  • Urinary Incontinence, Urge
  • Urinary Bladder, Overactive
  • Urinary Bladder Diseases
  • Urologic Diseases
  • Lower Urinary Tract Symptoms
  • Urological Manifestations

Interventions

  • INTIBIA TherapeuticDevice

    INTIBIA implantable tibial nerve stimulator with therapeutic stimulation

  • INTIBIA Non-TherapeuticDevice

    INTIBIA implantable tibial nerve stimulator with non-therapeutic stimulation for 3 months, then therapeutic stimulation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Response RateTime frame: 3 Months
  2. Response RateTime frame: 12 Months

Locations

22 sites in 2 countries. Site status is shown where the registry gives one.

  • Cedars-Sinai Medical Group

    Beverly Hills, California

  • Urology Group of Southern California

    Los Angeles, California

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.